The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Próximos ensaios clínicos
-
NCT07680075Ainda não está recrutandoHabilidades motoras | Saudável | Função executiva
-
NCT07680088Ainda não está recrutandoCarcinoma Anal de Células Escamosas
-
NCT07680101Ainda não está recrutandoArtrite reumatoide | Doença articular degenerativa do joelho
-
NCT07680114Ainda não está recrutando
-
NCT07680127Ainda não está recrutandoEdema Cerebral | Necrose de Radiação
-
NCT07680140Ainda não está recrutandoCetamina | fMRI | Depressão - Transtorno Depressivo Maior | rTMS | Depressão resistente ao tratamento (TRD)
-
NCT07680153Ainda não está recrutandofMRI | Transtorno Bipolar (DB) | rTMS | Depressão Bipolar 1
-
NCT07680166Ainda não está recrutando
-
NCT07680179Ainda não está recrutandoSuicídio | Prevenção do Suicídio
-
NCT07680205RecrutamentoFeocromocitoma | Feocromocitoma/Paraganglioma | Feocromocitoma Metastático | Feocromocitoma Maligno | Feocromocitoma e paraganglioma (PPGL)
-
NCT07680244RecrutamentoMembrana Epirretiniana | Doença da Retina | Degeneração macular relacionada à idade seca | Anormalidade Vitreorretiniana | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal Pigment Epithelium (RPE) Atrophy
-
NCT07680257Recrutamento